Skip to main content

Are you Dr. Habal?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 50 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    6501 Loisdale Ct
    Kaiser Permanente Springfield Medical Center
    Springfield, VA 22150
    Phone+1 703-922-1000

Summary

  • Dr. Nadia Habal, MD is a rheumatologist in Springfield, Virginia. She is currently licensed to practice medicine in Virginia, District of Columbia, and Maryland.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Rheumatology, 2009 - 2011
  • Texas Health Resources (Dallas)
    Texas Health Resources (Dallas)Residency, Internal Medicine, 2006 - 2009
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 2005 - 2006
  • The University of Texas Health Science Center at San Antonio
    The University of Texas Health Science Center at San AntonioClass of 2005

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2013 - 2026
  • VA State Medical License
    VA State Medical License 2011 - 2026
  • DC State Medical License
    DC State Medical License 2013 - 2024
  • TX State Medical License
    TX State Medical License 2007 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Publications & Presentations

PubMed

Press Mentions

  • Yes, the FDA Employs Rheumatologists. Here’s Their Role
    Yes, the FDA Employs Rheumatologists. Here’s Their RoleApril 15th, 2020
  • FDA Update: New Drug Approvals, New & Expanded Indications, & More
    FDA Update: New Drug Approvals, New & Expanded Indications, & MoreMarch 12th, 2020
  • FDA Rheumatology Update: New Drug Approvals, plus Expanded Drug Indications & Safety Concerns
    FDA Rheumatology Update: New Drug Approvals, plus Expanded Drug Indications & Safety ConcernsFebruary 12th, 2020

Other Languages

  • Spanish, Arabic